Ravichand Madala, MD
Sleep Medicine · Grand Rapids, MINPI 1083730907
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.1% of the total across 125 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 46.0% of the total. Reporting peaked in 2024 at $751 and has fallen 66.7% since, to $250 in 2025.
Across 125 payments — averaging $25.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$1K
- Harmony Biosciences LLC$936
- Axsome Therapeutics, Inc.$375
- Inspire Medical Systems, Inc.$162
- Avadel CNS Pharmaceuticals, LLC$64
- Resmed Corp$51
- plus $121 from 3 others
What the payments were for
- Food & beverage$2,98194%
- Education$1876%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 46 | $1,458 |
| Harmony Biosciences LLC | 48 | $936 |
| Axsome Therapeutics, Inc. | 17 | $375 |
| Inspire Medical Systems, Inc. | 1 | $162 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $64 |
| Resmed Corp | 3 | $51 |
| ZOLL Respicardia, Inc. | 2 | $46 |
| Idorsia Pharmaceuticals US Inc | 3 | $45 |
| Electromed, Inc. | 2 | $31 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XYWAV$298
- Inspire Upper Airway Stimulation System$162
- Wakix$117
- XYREM$109
How this compares
$3,168 in reported general payments places this provider in the 75th percentile of 78 sleep medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 18 | $792 |
| Methylphenidate Hcl | 23 | $604 |
| Gabapentin | 35 | $440 |
| Clonazepam | 12 | $130 |
| Temazepam | 15 | $97 |
| Zolpidem Tartrate | 16 | $27 |
| Alprazolam | 15 | $19 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Grand Rapids
- Kelly WatersGrand Rapids$30K
- Albert HoGrand Rapids$10K
- Christopher MorganGrand Rapids$4K
- Jeremy PetrousGrand Rapids$4K
- Nancy Bender HausmanGrand Rapids$4K
- Jason ColesGrand Rapids$3K
- Daniel HerrickGrand Rapids$3K
- Soumya MadalaGrand Rapids$2K
- David ShenGrand Rapids$399
- Margaret RabishGrand Rapids$287
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.